Ab stract. Leber's he red i tary op tic neurop a thy (LHON) is a ma ter nally in her ited mito chon drial dis or der, lead ing to a se lec tive loss of ret i nal gan glion cells (RGC) and degen er a tion of the op tic nerve, which re sults in se vere vi sual im pair ment or even blind ness. The pri mary causes are point mu ta tions of the mi to chon drial DNA (mtDNA), as so ci ated with aminoacid ex changes in com plex I of the elec tron trans port chain (ETC), which are thought to dis turb ox i da tive ATP gen er a tion in the mi to chon dria. The ma jor side ef fect of the an ti bi otic ethambutol, com monly used in tu ber cu lo sis ther apy, is a retinopathy, which may lead to se lec tive RGC loss, if not detected in an early stage. More over, LHON was re ported to be elic ited by ethambutol in some mu ta tion car ri ers. Ob jec tive: The present study in tended to mea sure a pos si ble syner gism be tween mi to chon drial dys func tion, caused by the most com mon LHON mu ta tion (G11778A) and caused by ethambutol, which may lead to a higher cytotoxicity of the drug in LHON cells. Ma te rial: An NT2/D1 teratoma-de rived LHON cybrid line and the paren tal cells. Method: De ter mi na tion of ethambutol tox ic ity in both lines, us ing a microtiter tetrazolium as say, luminometric mea surement of ATP/ADP ra tios and de termi na tion of mtDNA copy num bers by Re altime PCR. Re sults: Short-term etham butol toxi city oc curred only at mmo lar concentrations, far be yond the es ti mated plasma peak concentrations of pa tients un der antibiotic ther apy. No sig nif i cant dif fer ence oc curred between both cell lines. The ATP/ADP ra tios in the cybrids were sur pris ingly low, but showed no cor re la tion with the mutational sta tus of drug-treated cells. The mtDNA copy num ber of treated LHON and pa ren tal cells did not dif fer sig nif i cantly. Con clu sions: Ethambutol shows no syn er gism with the most com mon pri mary LHON mu ta tion with re spect to mito chon drial en ergy pro duc tion or mtDNA rep li ca tion in cybrid cells, al though the is sue of ATP de cline should be fur ther ad dressed in neuronally dif fer en ti ated cybrids with complete OXPHOS de pend ency.
Introduction
Leber's he red i tary op tic neu rop a thy (LHON), a neuroophthalmologic dis ease originally dis cov ered by the Ger man oph thalmol o gists von Graefe and Leber in the mid dle of the 19th cen tury [Leber 1871 , von Graefe 1858 , is mean while known to be a ma ter nally in her ited mi to chon drial dis or der [Wallace et al. 1988] . Its pri mary cause are point mu tations of the mi to chon drial DNA (mtDNA), which lead to the ex change of a sin gle amino acid of NADH : ubiquinone oxidoreductase, a large L-shaped pro tein com plex (com plex I) in the in ner mi to chon drial mem brane, donated to in tro duce NADH de rived elec trons into the elec tron trans port chain (ETC). The lo ca tion of the mu ta tions in com plex I and early bio chem i cal stud ies sug gested an altered ubiquinol site and en hanced prod uct inhi bi tion of the mu tated com plex [Carelli et al. 1999 , Majander et al. 1996 . While a de creased en zyme ac tiv ity in mu tant lymphoblasts, skin fibroblasts or cybrid cells re mains contro versal for the most com mon mu ta tion G11778A, com plex I res pi ra tion was found to be decreased in sev eral stud ies [Brown et al. 2000 , Floreani et al. 2005 . More over, the neu rol ogist Valerio Carelli and co work ers dem onstrated a clear de fect in ox i da tive ATP syn thesis [Baracca et al. 2005] as well as in cel lu lar ATP con tent un der met a bolic stress con ditions in a cybrid model [Zanna et al. 2003 [Zanna et al. , 2005 , re sult ing in en hanced apoptotic sen sitiv ity of the LHON cybrids. These and other ob ser va tions fa vored strongly the hy poth e sis of ret i nal gan glion cell (RGC) death, me diated by a com bi na tion of neuronal ATP de ficiency and en hanced superoxide gen er a tion in com plex I [Carelli et al. 2004a] . Ac cord ing to this hy poth e sis, the se lec tive vul ner a bil ity of RGC may be caused by their high ox i da tive en ergy de mand. The axon sec tions in the ret inal nerve fi ber layer are unmyelinated, thus requiering more mi to chon drial ATP to save the plasma mem brane po ten tial. This ar gument is un der lined by the stron ger histochemical cytochrome c oxidase stain ing of these intraocular por tions of the op ti cal ax ons [Carelli et al. 2004b] . Al though the pri mary causes of LHON are known, ad di tional factors in flu ence the like li hood of dis ease in muta tion car ri ers. This can be con cluded from the in com plete penetrance, rang ing be tween 25% and 80% in dif fer ent pop u la tions and stud ies [Mackey and But tery 1992, Man et al. 2003, www.ncbi.nlm.nih.gov/omim] , and from the strong male pre dom i nance. While the lat ter sug gests the par tic i pa tion of a yet unknown, recessive X-al lele [Hud son et al. 2005] , the dis ease-pro mot ing role of al co hol abuse [Sadun et al. 2002 [Sadun et al. , 2003 [Sadun et al. , 2004 un derlines the im por tance of epigenetic fac tors, target ing the ret ina.
One such fac tor may be the an ti bi otic ethambutol (EMB), which has com monly been used since 1961 to treat tu ber cu lo sis [Fraunfelder et al. 2006] . The most prom i nent EMB side ef fect is a retinopathy, which re sembles LHON in mul ti ple fea tures and was called ethambutol op ti cal neu rop a thy (EBON) by Ikeda and col leagues [Ikeda et al. 2006] . This type of retinopathy is also char ac ter ized by a se vere loss of vi sual acu ity, dis turbed color vi sion and cen tral scotoma. Like LHON, the dis ease pre dom i nantly af fects the smaller RGC of the macula and the cor re spond ing smaller ax ons of the papillomacular bun dle. In con trast to LHON, the dis ease is most of ten re vers ible af ter chang ing the an ti bi otic regime, if de tected at an early stage by the ophthal mol o gist. It may, how ever, procede to severe vi sual im pair ment or blind ness, in some cases even af ter early de tec tion of the symptoms and drug ommission. In re cent years, some cases of G11778A mu ta tion car ri ers have been de scribed, which de vel oped LHON dur ing an ti bi otic EMB treat ment and were orig i nally rec og nized in this way as muta tion car ri ers (sum ma rized by [Ikeda et al. 2006] ).
This sit u a tion led us to ex am ine the cytotoxicity of EMB in a cybrid cell cul ture model. For this pur pose, NT2/D1 teratoma-derived transmitochondrial cybrid cells, in which the tu mor mtDNA had been completely re placed by the mtDNA of a G11778A LHON pa tient [Wong et al. 2002] , were compared with the pa ren tal cell line. This of fers the pos si bil ity to com pare cells with and without the LHON mu ta tion un der con di tions of an iden ti cal chro mo somal back ground. Af ter es tab lish ing EMB dose re sponse curves in a cytotoxicity as say, ATP/ADP ra tios were meas ured as a di rect in di ca tor of al tered ox i dative phosphorylation (OXPHOS). Furthermore mtDNA copy num bers were mea sured with re spect to the hy poth e sis, that EMB may in hibit mtDNA rep li ca tion and, thus, in directly im pair OXPHOS.
Materials and methods

Cell lines and genetic confirmation
The Ntera-2 clone D1 (NT2/D1) teratoma cell line was pur chased from the Amer i can Type Cul ture Col lec tion (AT C C , Manassas, VA, USA). The NT2/D1-de rived LHON cybrid clone was a kind gift from Prof. Dr. Gino Cortopassi and Prof. Dr. Al ice Wong from the Uni ver sity of Cal i for nia (Da vis, CA, USA). The nu clear ge netic iden tity of both cell lines was proven by iden ti cal allelic pat terns of a col lec tion of microsatellite mark ers and amelogenin, us ing the MenType Nonaplex II PCR kit (BioType, Dresden, Ger many) as described else where [Schoeler et al. 2007] . In brief, the poly mor phic marker re gions were PCR-am pli fied with flu o res cence-la beled pri mers and re ac tion prod ucts un der went elec tro pho re sis on an ABI310C cap il lary sequencer (Ap plied Biosystems, Fos ter City, CA, USA), fol lowed by au to matic al lele identi fi ca tion by the GeneScan soft ware (Ap plied Biosystems). No allelic dif fer ences were observed. The pres ence of 100% mu tant G -11778A mtDNA in the LHON cybrid clone was proven by di rect se quenc ing and a specific PCR-RFLP as say, as de scribed in de tail else where [Schoeler et al. 2007 ]. In brief, the lat ter as say con sisted of a PCR of the ND4 region of the mtDNA, fol lowed by a di gest with the re stric tion endonuclease SfaNI. While the mu ta tion con fers re sis tance to the di gest, the wild type is cut. 6-FAM-la beled PCR frag ments were sep a rated on an ABI310C cap il lary se quencer, fol lowed by au to matic frag ment iden ti fi ca tion by the GeneScan software. The sta bil ity of the LHON mu ta tion was checked over the whole time pe riod of the work. No re main ing wild type DNA could be mea sured within the sen si tiv ity limit of the as say (< 1%) in all sub se quent rounds of cell cul ture. The ab sence of the three pri mary LHON mutations at nu cle o tide po si tions 14484, 3460 and 11778 in the NT2/D1 line was checked by di rect se quenc ing and for the lat ter two mu ta tions with an PCR-RFLP assay, as de scribed else where [Schoeler et al. 2007] . Fur ther more, se quenc ing re vealed no other patho genic mu ta tions which dis tinguished the mtDNAs of the two clones. The only ad di tional dif fer ences ob served were known poly morphisms.
Cell culture and EMB treatment
All cell lines were cul tured in high glucose (4.5 g/l) DMEM with a low ered bi carbon ate con tent (1.5 g/l) from AT C C , sup plemented with 1 mM so dium pyruvate, 4 mM L-glutamine, 10% fe tal calf se rum (EUGold, PAA, Linz, Austia) and 1% penicil line/streptomycine (PAA). Cells were cul tured in T75 flasks at 37 °C in 5% CO 2 at mo sphere, un til 80% confluency was reached. They were split by trypsinization in a ra tio of 1 : 4 or higher. For ex per i ments in 96-, 48-or 24-well plates, an ad e quate cell num ber per well (see re sults sec tion) was seeded and in cu bated for 24 h. Af ter this preincubation, var i ous con cen trations of EMB (Riemer Arzneimittel AG, Greifs wald, Ger many) were ap plied for the in di cated time pe ri ods, fol lowed by microtiter-tetrazolium (MTT) cell sur vival as say. For ATP/ADP and mtDNA copy num ber assays, the cells were seeded in the in di cated den sity (see re sults) in 6-well plates, treated with var i ous EMB con cen tra tions and subjected to lysis in ATP buffer or DNA ex traction, re spec tively. Since the dif fer en ti a tion sta tus of the cybrid lines was sus pected to influ ence their OXPHOS de pend ency, cell survival and ATP/ADP ra tios were also measured, fol low ing a short-term dif fer en ti a tion with retinoic acid (RA), which stopped cell pro lif er a tion. This was achieved by seed ing cells as usual, but re plac ing DMEM af ter a 24-h in cu ba tion by se rum-free Neurobasal (Invitrogen, Karlsruhe, Ger many), en riched with 5% B27 sup ple ment (Invitrogen) and 10 mM all-trans retinoic acid (RA) from Sigma (St. Louis, USA). Cells were in cu bated in this me dium for 4 days, prior to the in di cated ethambutol treat ment.
MTT assay
For the microtiter-tetrazolium as say one vol ume of cell cul ture me dium, con tain ing 1.5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-di phenyl ter tra zolium (MTT, Sigma, St. Loius, USA) was added to the cul ture wells and in cu bated at 37 °C for fur ther 2 h. Thereaf ter, the me dium was re placed by DMSO, which lysed the cells and dis solved the gen erated formazan dye. Op ti cal den si ties (OD) at 562 nm (ref er ence wave length 630 nm) were mea sured in a microplate reader, and cell survival was ex pressed as the OD per cent age, nor mal ized to untreated controls.
ATP/ADP ratio
Af ter trypsinization, cells were shortly washed 2 times in phos phate-buf fered sa line (PBS), re sus pend ed in 300 ml boil ing ATP buffer (100 mM Tris pH 7.75, 10 mM KCl, 4 mM MgCl 2 ) and boiled for fur ther 2 min. After a short high-speed centrifugation, the supernatant was dis trib uted into two fresh tubes. Af ter cool ing to room tem per a ture, 1.5 mM phosphoenolpyruvate (Sigma) and 6 units/ml pyruvate kinase (Sigma) were added to 1 of the 2 aliquots and in cu bated for 30 min at room tem per a ture, to phosphorylate all ADP in the sam ple to ATP. Af ter this step, the ali quot was boiled for 1 min, to de stroy the pyruvate kinase ac tiv ity. Then 50 ml of an appro pri ate di lu tion of both lysates (1 : 20 -1 : 50) was mixed with 50 ml of lu ci fer ase re action mix (CLS II ATP kit, Roche, Mannheim, Ger many). The re sult ing lu mi nes cence was im me di ately mea sured in a TD20/20 luminometer (Turner De sign In stru ments, Sunny vale, CA, USA). The ATP con cen tra tions of the sam ples were cal cu lated ac cord ing to a di lution se ries of a stan dard in the range be tween 62.5 nM and 500 nM. While the pyruvate kinase-treated lysate rep re sented the sum of ATP and ADP con cen tra tions, the un treated lysate rep re sented only ATP, al low ing the calcu la tion of ATP/ADP ra tios.
mtDNA copy number
To de ter mine the mtDNA copy num ber, nor mal ized to a nu clear sin gle copy gene, SYBR green Realtime PCR was used. To tal DNA was ex tracted from the EMB-treated cells in 6-well plates, us ing the QIAamp DNA Mini kit (Qiagen, Va len cia, CA, USA). Mi tochon drial DNA was am pli fied from these samples by the hypervariable re gion 2 (HVR2) primers: 5'-CTATCACCC TATT AACC ACT-3' (for ward) and 5'-GTTAAAAG TGCA -TACC GCCA-3' (re verse), while exon 8 of the p53 gene was the nu clear ref er ence amplicon: 5'-ACTGCCTCTTGCTTCTCTT-3' (forward) and 5'-AAGTGAATCTGA GGCA -TAAC-3' (re verse). The ref er ence amplicon had been found ear lier in our lab o ra tory to show no sig nif i cant dif fer ences be tween the two cell lines, if nor mal ized to var i ous other nu clear genes. It was cho sen to faciliate PCR by al low ing equal ther mal con di tions for both amplicons. PCR am pli fi ca tion was performed from 50 ng tem plate DNA with the QuantiTect kit (Qiagen, Va len cia, CA, USA) ac cord ing to the man u fac tur ers in struc tions on an ABI Prism 7000SDS cycler (Ap plied Biosystems). The ther mal con di tions were 2 min 50 °C, 10 min 95 °C, fol lowed by 40 cycles with 95 °C de na tur ation, 55 °C an neal ing and 72 °C ex ten sion, 30 sec each step. Copy num bers of both amplicons were au to mat ically cal cu lated by the cycler soft ware, us ing a di lu tion se ries of HVR2 and p53exon8 standards in the same run. The pu rity of re ac tion prod ucts was iden ti fied by their melt ing temper a ture.
Statistical analysis
Com par i sons of sur viv ing cell frac tions, ATP/ADP ra tios and mtDNA copy num bers un der EMB treat ment with the un treated controls were per formed us ing a 1-way ANOVA, to elu ci date whether the drug gen er ally had an ef fect on these pa ram e ters. The spe cific drug con cen tra tions, which ex hib ited a sta tis ti cally sig nif i cant dif fer ence to the con trols, were iden ti fied by a Dunnett post-hoc test. Sig nif icant dif fer ences be tween the two cell lines for a given EMB con cen tra tion were de ter mined by a t-test. All cal cu la tions were per formed with the soft ware pack age SPSS 13 (SPSS, Chi cago, USA), as sum ing sig nif i cance for p < 0.05. All di a grams show means ± SEM.
Results
Cell survival under EMB treatment
30.000 cells were seeded in 24-well plates in DMEM, in cu bated for 24 h and treated for an other 24 h with the EMB con cen tra tions indi cated in Fig ure 1 . The toxic ef fects, which could be mea sured in the MTT cell sur vival as say, were sur pris ingly low, even if mmo lar con cen tra tions of the drug were ap plied for this short time pe riod. Less than 30% of cells died at 2.7 mM, while the rel e vant con cen trations in vivo are thought to be in the range between 20 and 80 mM (see Dis cus sion). However, tox ic ity be came sig nif i cant (p < 0.01) in both cell lines for con cen tra tions above 1.2 mM in the Dunnett test and was clearly dosedependent. Al though the dose re sponse curve for the LHON mu tant was be neath that one of the wild type over the whole con cen tra tion range, the dif fer ence be tween the lines only be came sig nif i cant (p < 0.01) for the high est con cen tra tion tested (2.7 mM), which is thought to be ir rel e vant in vivo.
To elu ci date pos si ble ef fects of the plate type used, of cybrid dif fer en ti a tion and of EMB ex po sure times, sev eral sim i lar ex per iments were per formed. They all had es sentially the same re sults, and are, there fore, not shown in de tail in seperate Fig ures. All ex peri ments re vealed a clear dos age-de pend ent tox ic ity of the drug, but no proof of a higher sen si tiv ity of the LHON mu tant as com pared to the wild type.
In one se ries of ex per i ments, 3,000 cells per well were seeded into 96-well plates and the same EMB con cen tra tions, as shown in Fig ure 1 , were ap plied for 24 h. The tox ic ity Pommer, Schoeler, Mawrin et al. of the drug seemed to be some what higher in this as say, since the max i mal frac tion of dead cells reached about 40% for 2.7 mM EMB. The slight dif fer ence be tween both plate types may be due to the higher per cent age of cells, which are lost dur ing suck ing the cell cul ture liq uid out off the wells, since EMB seemed to re duce the ad he sion of the cells to plas tic sur faces. The drain ing of cells with low ered ad he sion be comes more prom i nent in smaller wells. In this as say vari ant, the dose re sponse curve of wild type NT2/D1 cells was usu ally be low that one of the LHON mu tant, al though this dif fer ence again be came sig nif icant only for the highest concentrations above 2.4 mM.
Even short-term dif fer en ti a tion with retinoic acid (RA) did not lead to an es sen tially dif fer ent out come. For this pur pose, 5,000 cells were seeded into 48-well plates, followed by 4 days RA dif fer en ti a tion, prior to the 24 h EMB treat ment in the same con centra tion range, as shown in Fig ure 1 . Again, a clearly dos age de pend ent tox ic ity of the drug oc curred, which was very sim i lar to that of un dif fer en ti ated cells. No el e vated sen si tiv ity of the mutant clone was found.
In vivo the drug in flu ences the ret i nal ganglion cells (RGC) over long-time pe ri ods of usu ally sev eral monthes. Al though a chronic treat ment could not be sim u lated in the MTT as say, the time pe riod of EMB in cu ba tion of the un dif fer en ti ated cells was ex tended in one experimental se ries to the pos si ble max imum of 4 days. This limit re sulted from the growth of the un treated con trols which died about 24 h af ter reach ing confluency. In all, 2,000 cells were seeded in 96-well plates. After 24 h of preincubation in DMEM, they were treated with the es tab lished EMB concen tra tions for a time pe riod of 4 days, prior to MTT as say. Af ter this pro longed in cu ba tion, tox ic ity reached a max i mum around 45% cell death for 2.7 mM EMB, very sim i lar to the results ob tained for the 24-h ex po sure. Again, the dos age-de pend ent ef fect was sta tis ti cally sig ni ficant, without increased response of the mutant.
Due to the lim ited EMB tox ic ity in the MTT as say, we in tended to find out whether ex tremely high con cen tra tions of the drug may cause a more pro nounced cell death in the LHON cybrids. Ex tend ing the con cen tration range to 12 mM lead to death of more than 80% of the cells, with out el e vated sen sitiv ity of the mu tant clone. While 50% death had not been reached in the pre vi ous ex per iments, the LD 50 could now be de ter mined to be around 4 mM in both cell lines. Taken together, all types of MTT as says did not re veal a higher sen si tiv ity of the mu tant against the cytotoxic effect of EMB.
For con cen tra tions above 0.5 mM, a clear morphologic change oc curred in both lines. Small vac u oles ap peared in phase-con trast mi cro graphs. Num ber and mean di am e ter of these vac u oles in creased with EMB con centra tion, but no ob vi ous dif fer ence was vis i ble in the mi cro scope be tween both cell lines. After 24 h in 2.7 mM of the drug, the cy to plasm was filled with large num bers of these vac uoles (Fig ure 2) . Their or i gin and im pact for the cells are yet unknown.
ATP/ADP ratio
Here 100,000 cells per well were seeded into 6-well plates, in cu bated 24 h in DMEM and ex posed to 0 (con trol), 0.6 or 2.7 mM EMB for 24 h, prior to the luminometric ATP/ADP as say. For ex per i ments with dif feren ti ated cy brids, only 50,000 cells were initially plated, but a 4-day dif fer en ti a tion was 1 . Sur viv ing cell frac tion (%) in re sponse to in creas ing EMB con cen tra tions (mM) for NT2/D1 pa ren tal cells (NT2) and cybrids with the G11778A mtDNA mu ta tion. * = sig nif i cant dif fer ence to untreated con trol cells (C) of the same line (p < 0.01). The star sym bol re fers to both lines, since a sig nif icant ef fect oc curred at iden ti cal con cen tra tions in both clones. # = sig nif i cant dif fer ence be tween the 2 lines for 2.7 mM EMB (p < 0.01).
in cluded in the pro to col, prior to EMB treatment.
Gen er ally, the en er getic sta tus of the cybrids was sur pris ingly low. The untreated LHON mu tants in DMEM did not show per se a sig nif i cantly lower ATP/ADP ra tio, when com pared with un treated NT2/D1 cells. This would have been in con cor dance with a hypoth e sis of the lit er a ture, as sum ing that prolif er at ing cybrid cells in DMEM pos ses a largely nonoxidative (glycolytic) en ergy metab o lism, which masks the ef fects of the muta tions. How ever, the LHON cells even exhib ited a higher ra tio, when com pared with the wild type (p < 0.05), a rather un ex pected re sult (Fig ure 3) . EMB se lec tively de creased the ra tio in the mu tant (p < 0.05), thus, lead ing to iden ti cal ATP/ADP ra tios in mu tant and wild type. This ex per i ment was not fi nally con clu sive. It sug gested no gen eral im pact of EMB on OXPHOS, since the en ergy sta tus of the wild type did not worsen un der the in fluence of the drug. On the other hand, a pos si ble in flu ence se lec tively in the mu tant clone was in con clu sive, since the sta tis ti cally sig nif icant ef fect of EMB in this clone de pended com pletely on the ab er rant be hav ior of the un treated LHON cells (Fig ure 3) .
For this rea son and due to the sug gested glycolytic en ergy me tab o lism of the un dif feren ti ated cybrids in DMEM, the ex per i ment was re peated with dif fer en ti ated cells (Fig ure  4) , which were thought to ex hibit en hanced OXPHOS de pend ency. In this case, no significant dif fer ences at all oc curred, nei ther between the cell lines, nor be tween treated and un treated groups. Taken to gether, these experi ments sug gest no ma jor in flu ence of EMB on OXPHOS.
mtDNA copy number 150,000 cells were seeded into each well of a 6-well plate. Af ter 24 h in DMEM, 0(control), 0.6 or 2.7 mM EMB were added. The cells were in cu bated in this me dium for 5 days, to al low some mtDNA turn over. The copy num ber of mtDNA, nor mal ized to a nuclear sin gle copy gene (p53), was as sayed by SYBR green Realtime PCR in the ex tracted DNA sam ples (Fig ure 5) . The cells con tained a mean of about 600 mtDNA cop ies per p53 copy. Al though, the mtDNA con tent in the paren tal cell line seemed to be slightly higher as com pared with the LHON cells, this dif ference did not reach sta tis ti cal sig nif i cance. EMB had no in flu ence on the mtDNA content, nei ther in the wild type, nor in the LHON cells, sug gest ing no influence on mtDNA replication.
Discussion
In a se ries of 24 pa tients with EMB-induced retinopathy, Hwang and col leagues [Hwang et al. 2003 ] did not find any of the known pri mary LHON mu ta tions. This suggested that the mu ta tion in ci dence in such patients is not in creased. How ever, this re sult does not con clu sively ex clude a syn er gism be tween ge netic sta tus and drug, since mu tation car ri ers are rel a tively rare in the gen eral population. On the other hand, sev eral carriers of the G11778A tran si tion had been iden ti fied by the de vel op ment of LHON during tu ber cu lo sis ther apy with EMB, sug gesting that the drug fa vors dis ease out break. This sug ges tion was un der lined by four cases (reviewed by [Ikeda et al. 2006] ), in which the age of LHON on set in two males and two females was be tween 53 and 70 years, while spo radic or fa mil ial LHON dis ease usu ally af fects young men in their first three de cades of life.
While the neurotoxic side ef fects of EMB are well-doc u mented in tu ber cu lo sis pa tients, the tox ic ity has not been well-de fined in RGC cul tures. In the last years, two groups in ves tigated these toxic ef fects in dis so ci ated rat ret - (11778), treated for 24 h with the in di cated EMB con cen tra tions. n = 5 in de pend ent ex per iments. Fig ure 3 . ATP/ADP ra tios of NT2/D1 pa ren tal cells (NT2) and LHON cybrids (11778) treated for 24 h with the in di cated EMB con cen tra tions. * = sig nif i cant differ ence to the cor re spond ing EMB-free con trol, # = sig nif i cant dif fer ence be tween the 2 lines, grow ing in DMEM with out the drug. n = 4 in de pend ent ex per iments.
i nal cell cul tures. Both groups ap plied the drug for 24 h di rectly to the me dium. Heng et al. [1999] used an MTT as say, but quan ti fied the formazan de po si tion se lec tively in RGC with a mi cro scop i cal tech nique. In their exper i ments, the most pro nounced de crease in vi a ble cell num ber oc curred for con cen trations be tween 1 mM and 100 mM, the lat ter con cen tra tion re sult ing in about 50% cell death. Sur pris ingly, even con cen tra tions in the mM range did not fur ther en hance cell death (Fig ure 1A of their pub li ca tion). In contrast, Yoon et al. [2000] mea sured a more linear de crease of the vi a ble cell num ber for EMB con cen tra tions be tween 200 mM and 1 mM, us ing di rect cell count ing of mor pholog i cally in tact MAP-2-pos i tive neu rons. Their dose re sponse curves sug gested an LD 50 around 800 mM (Fig ure 3A of their publi ca tion). Since the plasma peak con cen trations in EMB treated tu ber cu lo sis pa tients are in the range be tween 20 and 80 mM [Lee et al. 1977 , Peets et al. 1965 , the first study better re flects an im me di ate ef fect of these rel e vant con cen tra tions on RGC vi a bil ity, while the sec ond does not. How ever, cell cul ture studies can not de ter mine the long term proapoptotic ef fects of the drug, which might occur at much lower con cen tra tions. Since the teratoma cybrids, used in the pres ent study, are known to be less sen si tive against var i ous neurotoxic and pro apop totic stim uli as compared to pri mary neu ron cul tures, the lower sen si tiv ity to EMB treat ment was not sur prising. The LD 50 was around 4 mM for a 24-h ap pli ca tion. A se lec tively higher sen si tiv ity of the LHON cybrids was not ob served. In terest ingly, at drug con cen tra tions of 500 mM or higher, many vac u oles ac cu mu lated in the cyto plasm. With re spect to this fea ture, the cybrids be haved largely like cul tured RGC, which ac cu mu lated these vac u oles at a concen tra tion range be tween 700 and 1,000 mM [Yoon et al. 2000] . The na ture of these vac uoles re mains un known. They seemed to be sur rounded by only a sin gle mem brane and, thus, not to be of mi to chon drial, but even tually of ER or Golgi or i gin. Al though the cy toplasm may be come densely filled with vac uoles, their ap pear ance is re vers ible, since they dis ap peared af ter re mov ing EMB from RGC cul tures.
The mech a nism of EMB neurotoxicity remains un clear up to now, but a di rect at tack of OXPHOS com plexes had been hy poth e sized as one pos si bil ity. The known cop per che lating ef fect of the drug was sug gested to lead to in hi bi tion of cytochrome c oxidase (COX) activ ity [Ikeda et al. 2006] . This in hi bi tion may cause a sig nif i cant re duc tion of elec tron flux through the ETC, thus, di min ish ing ox i da tive ATP syn the sis. In the highly ATP de mand ing, unmyelinated intraocular por tions of RGC ax ons, this OXPHOS re duc tion may lead to AT P de fi ciency and cell death. A direct OXPHOS in ter fer ence would be as sumed to be fast and, thus, to be mea sur able in LHON cybrid cul tures. COX ac tiv i ties or res pi ra tion rates of EMB treated cells could not be measured di rectly in the pres ent study with re li able bio chem i cal meth ods. This ap proach re quires rel a tively high cell num bers, which were not avail able, es pe cially not fol low ing RA treatment. In con trast, a re sult ing ATP de cline can eas ily be mon i tored us ing min i mal amounts of cells, but it must be kept in mind that cybrid cells may rely mainly on glyco lytic ATP gener a tion, un less they are forced to switch to the ox i da tive path way. Al though a short-term RA dif fer en ti a tion of the teratoma based cybrids was ap plied in the pres ent stu dy, to en hance their OXPHOS de pend ency, even these cultures may still rely mainly upon glycolytic ATP gen er a tion. This may ham per the de tection of pos si ble OXPHOS ef fects of EMB. More over, the lim ited mor pho log i cal ef fect of EMB sug gests a low ef fi cacy in the model. The prob lem may be solved by ap ply ing the drug to cybrids af ter ter mi nal neuronal dif fer -
